Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test.
Psychopharmacology October 19, 2023 Arya Rahbarnia, Zhaoxia Li, Paul J Fletcher 9 citations
Neuropsychiatric disorders such as depression are characterized in part by attention deficits. Attention is modulated by the serotonin (5-HT) neurotransmitter system. The 5-HT2A agonist and hallucinogen psilocybin (PSI) is a promising treatment for disorders characterized by attention changes. However, few studies have investigated PSI's direct effect on attention. Using the rodent continuous...
DOI: 10.1007/s00213-023-06474-9 (opens in new tab)
Full text (opens in new tab)
Psilocybin
Serotonin
5-ht2a
Continuous performance test
+11